FDA guidance about improving diversity in studies has gained momentum and continues to do so. It has always been a goal of nearly every clinical research professional, but achieving it has been historically difficult, how has this changed since the guidance was issued. This webinar will discuss some of major changes but also the key obstacles that still stand in the way.
